Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas

NCT00274755 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators